Shares of Ondine Biomedical Inc. (LON:OBI – Get Free Report) fell 2% during trading on Tuesday . The stock traded as low as GBX 8.58 ($0.11) and last traded at GBX 8.62 ($0.11). 158,609 shares changed hands during mid-day trading, a decline of 6% from the average session volume of 168,652 shares. The stock had previously closed at GBX 8.80 ($0.11).
Ondine Biomedical Stock Down 2.6 %
The company has a market cap of £24.30 million, a P/E ratio of -292.17 and a beta of 0.10. The company has a debt-to-equity ratio of 1,847.37, a quick ratio of 8.26 and a current ratio of 0.80. The business’s fifty day moving average is GBX 8.30 and its two-hundred day moving average is GBX 7.63.
Ondine Biomedical Company Profile
Ondine Biomedical Inc, a Life sciences company, engages in the research, development, and commercialization of antimicrobial photodisinfection therapies in Canada and internationally. Its product platform is Photodisinfection, a topical light-based antimicrobial technology that eliminates harmful pathogens.
Featured Stories
- Five stocks we like better than Ondine Biomedical
- What is a buyback in stocks? A comprehensive guide for investors
- MercadoLibre: Latin America’s Digital Titan Just Got Cheaper
- What to Know About Investing in Penny Stocks
- Breaking Down Pegasystems, A Wedbush Top AI Pick for 2025
- Profitably Trade Stocks at 52-Week Highs
- Shutterstock and Getty: A $3.7 Billion Visual Content Giant
Receive News & Ratings for Ondine Biomedical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ondine Biomedical and related companies with MarketBeat.com's FREE daily email newsletter.
